▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Alex Carchidi

TMFacarchidi

Alex began writing for the Fool in early 2020 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing.

Recent Articles by Alex Carchidi

three scientists work in laboratory with one looking down a microscope

Nov 28, 2024 by Alex Carchidi

Is This a New Reason to Buy Pfizer Stock Hand Over Fist?

three scientists look at tablet while worried

Nov 27, 2024 by Alex Carchidi

Is Amgen Stock Still a Buy After an Unexpected Reveal of Data?

two investors consider a stock with laptop

Nov 27, 2024 by Alex Carchidi

Is Novo Nordisk Stock a Buy?

cannabis worker examines cannabis plant with scope

Nov 26, 2024 by Alex Carchidi

Is Tilray Brands Stock a Buy?

scientist looks into microscope while sitting at bench in laboratory

Nov 26, 2024 by Alex Carchidi

Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow

three scientists chat at a lab bay

Nov 22, 2024 by Alex Carchidi

Where Will Bristol Myers Squibb Be in 5 Years?

two investors consider a laptop

Nov 21, 2024 by Alex Carchidi

3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move

two scientists work at lab bench

Nov 22, 2024 by Alex Carchidi

Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back

two older investors smile while looking at papers

Nov 21, 2024 by Alex Carchidi

Investing in Pharma Stocks? Check These 3 Things First

scientist looks into microscope while sitting at lab bench

Nov 21, 2024 by Alex Carchidi

Down 33% in 1 Month, Should You Buy the Dip With Intellia Therapeutics Stock?

two investors put sticky notes on glass wall

Nov 18, 2024 by Alex Carchidi

Where Will AbbVie Be in 5 Years?

lab research scientists women in STEM

Nov 15, 2024 by Alex Carchidi

3 Things You Need to Know if You Buy Viking Therapeutics Today

scientist examines samples with microscope while in laboratory

Nov 15, 2024 by Alex Carchidi

2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious

Its future is bright, but that doesn't mean it'll always be smooth sailing.

scientists doing research in lab

Nov 15, 2024 by Alex Carchidi

2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More

scientists lab testing blood draw(2)

Nov 13, 2024 by Alex Carchidi

Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its Stock

The drugmaker has convincingly laid the biggest threat to its top line to rest.

lab scientist beaker

Nov 13, 2024 by Alex Carchidi

Where Will CRISPR Therapeutics Be in 3 Years?

healthcare lab treatment research scientist

Nov 8, 2024 by Alex Carchidi

Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?

The good times aren't over, but the peak of the party might be passing.

concerned investor with two people in background

Nov 9, 2024 by Alex Carchidi

1 Stubborn Cloud and 2 Silver Linings for Eli Lilly Stock

Conditions are getting a bit more challenging for the drugmaker.

investor holds glasses while considering laptop

Nov 8, 2024 by Alex Carchidi

1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More

There's a bright future ahead for this company.

researchers in lab

Nov 7, 2024 by Alex Carchidi

4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move

All signs are pointing toward its continued success.

HOW THE MOTLEY FOOL CAN HELP YOU

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services